| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| AIDS-Associated Nephropathy | 71 | 2022 | 76 | 11.600 |
Why?
|
| HIV-1 | 81 | 2022 | 465 | 7.900 |
Why?
|
| Kidney | 68 | 2020 | 1337 | 3.600 |
Why?
|
| Podocytes | 21 | 2020 | 79 | 3.240 |
Why?
|
| HIV Infections | 36 | 2022 | 1864 | 2.290 |
Why?
|
| Kidney Diseases | 21 | 2013 | 478 | 2.040 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 10 | 2014 | 26 | 1.610 |
Why?
|
| Kidney Glomerulus | 13 | 2020 | 80 | 1.430 |
Why?
|
| Mice, Transgenic | 51 | 2022 | 2391 | 1.360 |
Why?
|
| Kidney Failure, Chronic | 17 | 2020 | 866 | 1.320 |
Why?
|
| Anti-HIV Agents | 13 | 2010 | 305 | 1.110 |
Why?
|
| Acquired Immunodeficiency Syndrome | 11 | 2015 | 230 | 1.030 |
Why?
|
| Animals | 129 | 2022 | 33693 | 1.020 |
Why?
|
| Gene Products, vpr | 4 | 2022 | 20 | 0.950 |
Why?
|
| Mice | 83 | 2022 | 17469 | 0.950 |
Why?
|
| Antiretroviral Therapy, Highly Active | 11 | 2015 | 265 | 0.900 |
Why?
|
| Immunoglobulin G | 4 | 2010 | 771 | 0.890 |
Why?
|
| Gene Products, nef | 6 | 2006 | 14 | 0.880 |
Why?
|
| Ion Channels | 4 | 2008 | 188 | 0.830 |
Why?
|
| Membrane Proteins | 8 | 2014 | 1524 | 0.830 |
Why?
|
| Kidney Tubules | 11 | 2012 | 82 | 0.740 |
Why?
|
| Myosin Heavy Chains | 6 | 2014 | 77 | 0.720 |
Why?
|
| Molecular Motor Proteins | 5 | 2014 | 29 | 0.710 |
Why?
|
| Actins | 3 | 2014 | 341 | 0.690 |
Why?
|
| Gene Expression | 18 | 2013 | 1569 | 0.650 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 7 | 2014 | 17 | 0.650 |
Why?
|
| Gene Expression Regulation, Viral | 11 | 2011 | 133 | 0.640 |
Why?
|
| Glomerular Mesangium | 7 | 1999 | 19 | 0.640 |
Why?
|
| Genes, Viral | 8 | 2008 | 183 | 0.630 |
Why?
|
| Disease Models, Animal | 23 | 2022 | 4263 | 0.630 |
Why?
|
| Genetic Therapy | 7 | 2008 | 662 | 0.610 |
Why?
|
| Transforming Growth Factor beta | 12 | 2004 | 456 | 0.590 |
Why?
|
| Cells, Cultured | 22 | 2018 | 3050 | 0.570 |
Why?
|
| Humans | 138 | 2022 | 122997 | 0.550 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2013 | 239 | 0.530 |
Why?
|
| Malate Dehydrogenase | 2 | 2008 | 4 | 0.520 |
Why?
|
| Hypertension, Renovascular | 8 | 1996 | 29 | 0.510 |
Why?
|
| Apoptosis | 9 | 2010 | 1783 | 0.510 |
Why?
|
| DNA-Binding Proteins | 8 | 2018 | 2048 | 0.510 |
Why?
|
| Cytosol | 2 | 2008 | 159 | 0.500 |
Why?
|
| Kidney Tubules, Proximal | 5 | 2011 | 109 | 0.500 |
Why?
|
| RNA, Messenger | 24 | 2014 | 2820 | 0.500 |
Why?
|
| Kidney Transplantation | 14 | 2020 | 627 | 0.490 |
Why?
|
| Glycoproteins | 4 | 2013 | 369 | 0.470 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2010 | 144 | 0.460 |
Why?
|
| Nonmuscle Myosin Type IIA | 3 | 2012 | 7 | 0.450 |
Why?
|
| Extracellular Matrix Proteins | 7 | 1998 | 149 | 0.450 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2007 | 34 | 0.450 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2018 | 522 | 0.440 |
Why?
|
| Cell Adhesion Molecules | 3 | 2010 | 225 | 0.440 |
Why?
|
| Internal Medicine | 3 | 2011 | 147 | 0.430 |
Why?
|
| Neointima | 1 | 2013 | 43 | 0.430 |
Why?
|
| Renal Insufficiency | 4 | 2012 | 233 | 0.430 |
Why?
|
| Cell Movement | 2 | 2013 | 831 | 0.430 |
Why?
|
| Gene Expression Regulation | 10 | 2014 | 2533 | 0.430 |
Why?
|
| Animals, Genetically Modified | 2 | 2009 | 316 | 0.420 |
Why?
|
| Virus Replication | 10 | 2011 | 600 | 0.420 |
Why?
|
| Rats | 31 | 2006 | 3629 | 0.410 |
Why?
|
| Renal Circulation | 10 | 1994 | 45 | 0.400 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2013 | 119 | 0.400 |
Why?
|
| STAT3 Transcription Factor | 6 | 2013 | 217 | 0.390 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 8 | 2013 | 210 | 0.380 |
Why?
|
| Laminin | 10 | 1996 | 59 | 0.370 |
Why?
|
| Tretinoin | 3 | 2012 | 116 | 0.370 |
Why?
|
| DNA, Viral | 7 | 2009 | 477 | 0.370 |
Why?
|
| Molecular Sequence Data | 19 | 2010 | 3871 | 0.370 |
Why?
|
| Muscle Proteins | 2 | 2018 | 417 | 0.370 |
Why?
|
| Teaching Rounds | 1 | 2011 | 28 | 0.360 |
Why?
|
| Anti-Retroviral Agents | 3 | 2008 | 135 | 0.360 |
Why?
|
| Proteomics | 1 | 2014 | 480 | 0.360 |
Why?
|
| Juxtaglomerular Apparatus | 4 | 1994 | 7 | 0.360 |
Why?
|
| Caspase 8 | 1 | 2010 | 21 | 0.360 |
Why?
|
| Collagen | 10 | 1999 | 312 | 0.350 |
Why?
|
| Ubiquitins | 2 | 2009 | 42 | 0.350 |
Why?
|
| Renin | 12 | 1996 | 89 | 0.340 |
Why?
|
| Epithelial Cells | 10 | 2013 | 900 | 0.340 |
Why?
|
| RNA, Viral | 11 | 2010 | 540 | 0.340 |
Why?
|
| Transduction, Genetic | 4 | 2008 | 277 | 0.340 |
Why?
|
| Genes, nef | 2 | 2008 | 3 | 0.340 |
Why?
|
| Integrins | 4 | 1994 | 81 | 0.340 |
Why?
|
| Thromboxanes | 5 | 1992 | 10 | 0.340 |
Why?
|
| Cell Differentiation | 10 | 2012 | 1915 | 0.330 |
Why?
|
| Polymerase Chain Reaction | 9 | 2010 | 1586 | 0.330 |
Why?
|
| Microvilli | 5 | 2005 | 72 | 0.330 |
Why?
|
| Captopril | 8 | 1996 | 28 | 0.320 |
Why?
|
| Cardiomyopathies | 3 | 2018 | 481 | 0.320 |
Why?
|
| Calcium | 4 | 2005 | 1096 | 0.320 |
Why?
|
| Proteinuria | 9 | 2012 | 110 | 0.320 |
Why?
|
| Transgenes | 8 | 2008 | 326 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2011 | 3090 | 0.320 |
Why?
|
| Health Care Reform | 2 | 2009 | 50 | 0.320 |
Why?
|
| Up-Regulation | 5 | 2018 | 867 | 0.310 |
Why?
|
| Glomerular Filtration Rate | 12 | 2013 | 481 | 0.310 |
Why?
|
| Cytokinesis | 1 | 2008 | 27 | 0.310 |
Why?
|
| Cyclic AMP | 3 | 2012 | 247 | 0.300 |
Why?
|
| Cell Division | 10 | 2013 | 779 | 0.300 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2011 | 474 | 0.300 |
Why?
|
| Fibronectins | 8 | 1994 | 104 | 0.290 |
Why?
|
| src-Family Kinases | 2 | 2006 | 91 | 0.290 |
Why?
|
| Apolipoproteins | 3 | 2012 | 68 | 0.290 |
Why?
|
| Renal Artery Obstruction | 4 | 1994 | 41 | 0.290 |
Why?
|
| Nucleic Acids | 2 | 2005 | 23 | 0.290 |
Why?
|
| Benzoxazines | 1 | 2007 | 24 | 0.290 |
Why?
|
| Cytoskeleton | 2 | 2008 | 178 | 0.290 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2022 | 715 | 0.290 |
Why?
|
| Lipoproteins, HDL | 3 | 2012 | 96 | 0.290 |
Why?
|
| Models, Animal | 2 | 2006 | 465 | 0.280 |
Why?
|
| Urine | 1 | 2007 | 88 | 0.280 |
Why?
|
| Organophosphonates | 1 | 2007 | 19 | 0.280 |
Why?
|
| Base Sequence | 13 | 2007 | 3093 | 0.280 |
Why?
|
| Rats, Inbred Strains | 14 | 1994 | 224 | 0.270 |
Why?
|
| Cell Adhesion | 9 | 2011 | 321 | 0.270 |
Why?
|
| Cell Proliferation | 8 | 2013 | 2306 | 0.270 |
Why?
|
| Adenine | 1 | 2007 | 99 | 0.270 |
Why?
|
| Risk Factors | 17 | 2022 | 9974 | 0.260 |
Why?
|
| Urban Health | 2 | 2007 | 73 | 0.260 |
Why?
|
| Cell Line | 11 | 2011 | 2779 | 0.260 |
Why?
|
| Blotting, Northern | 8 | 2007 | 258 | 0.260 |
Why?
|
| HIV Long Terminal Repeat | 3 | 2001 | 19 | 0.260 |
Why?
|
| Nephrology | 2 | 2009 | 144 | 0.250 |
Why?
|
| Collagenases | 3 | 1996 | 18 | 0.250 |
Why?
|
| Diabetic Nephropathies | 3 | 2018 | 110 | 0.250 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2008 | 111 | 0.250 |
Why?
|
| Genetic Vectors | 4 | 2002 | 924 | 0.250 |
Why?
|
| Male | 59 | 2015 | 59901 | 0.250 |
Why?
|
| RNA, Catalytic | 3 | 2004 | 15 | 0.240 |
Why?
|
| Amino Acid Sequence | 10 | 2010 | 2698 | 0.240 |
Why?
|
| Lentivirus | 2 | 2002 | 84 | 0.240 |
Why?
|
| Quality of Health Care | 1 | 2008 | 391 | 0.240 |
Why?
|
| Fetus | 5 | 2000 | 570 | 0.240 |
Why?
|
| Cell Membrane | 5 | 2010 | 459 | 0.230 |
Why?
|
| Adult | 39 | 2015 | 28980 | 0.230 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 319 | 0.230 |
Why?
|
| Glomerulonephritis | 5 | 2010 | 73 | 0.230 |
Why?
|
| HIV | 2 | 2020 | 179 | 0.230 |
Why?
|
| Middle Aged | 34 | 2020 | 25931 | 0.230 |
Why?
|
| CD4 Lymphocyte Count | 6 | 2007 | 229 | 0.230 |
Why?
|
| Albuminuria | 4 | 2013 | 91 | 0.230 |
Why?
|
| Lipid Bilayers | 3 | 2002 | 46 | 0.230 |
Why?
|
| Graft Rejection | 7 | 1999 | 582 | 0.220 |
Why?
|
| Zidovudine | 2 | 2002 | 22 | 0.220 |
Why?
|
| Time Factors | 13 | 2013 | 6198 | 0.220 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2002 | 135 | 0.220 |
Why?
|
| Thromboxane-A Synthase | 6 | 1992 | 16 | 0.220 |
Why?
|
| Delivery of Health Care | 2 | 2009 | 606 | 0.220 |
Why?
|
| Signal Transduction | 9 | 2018 | 4507 | 0.210 |
Why?
|
| Receptors, Angiotensin | 2 | 1994 | 21 | 0.210 |
Why?
|
| Hypertension | 7 | 1998 | 1277 | 0.210 |
Why?
|
| Phosphorylation | 7 | 2013 | 1610 | 0.200 |
Why?
|
| Nephritis, Interstitial | 2 | 2011 | 37 | 0.200 |
Why?
|
| Angiotensin II | 5 | 1998 | 161 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2006 | 1211 | 0.200 |
Why?
|
| Nephrons | 1 | 2001 | 20 | 0.200 |
Why?
|
| Urothelium | 1 | 2002 | 60 | 0.200 |
Why?
|
| Cytokines | 2 | 2006 | 1280 | 0.190 |
Why?
|
| Prevalence | 8 | 2010 | 2393 | 0.190 |
Why?
|
| Hypertension, Renal | 3 | 2012 | 37 | 0.190 |
Why?
|
| Biopsy | 8 | 2018 | 1239 | 0.190 |
Why?
|
| Disease Outbreaks | 3 | 2009 | 320 | 0.190 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2001 | 85 | 0.190 |
Why?
|
| Purines | 1 | 2001 | 107 | 0.190 |
Why?
|
| Flavonoids | 1 | 2001 | 78 | 0.190 |
Why?
|
| Epoprostenol | 2 | 1993 | 67 | 0.190 |
Why?
|
| Cysts | 1 | 2001 | 100 | 0.180 |
Why?
|
| Receptors, Retinoic Acid | 3 | 2012 | 100 | 0.180 |
Why?
|
| Cyclosporins | 3 | 1990 | 74 | 0.180 |
Why?
|
| Tissue Distribution | 5 | 2004 | 374 | 0.180 |
Why?
|
| Renal Dialysis | 4 | 2002 | 842 | 0.180 |
Why?
|
| Cell Line, Transformed | 6 | 2013 | 170 | 0.180 |
Why?
|
| In Vitro Techniques | 6 | 2010 | 966 | 0.180 |
Why?
|
| Transfection | 4 | 2013 | 1068 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2004 | 798 | 0.180 |
Why?
|
| Microfilament Proteins | 5 | 2009 | 277 | 0.180 |
Why?
|
| Incidence | 7 | 2015 | 3047 | 0.180 |
Why?
|
| Disease Progression | 8 | 2013 | 2027 | 0.180 |
Why?
|
| Potassium Deficiency | 2 | 1993 | 12 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2013 | 137 | 0.180 |
Why?
|
| Cachexia | 3 | 1996 | 48 | 0.180 |
Why?
|
| United States | 15 | 2011 | 10595 | 0.180 |
Why?
|
| Piperidines | 1 | 2001 | 198 | 0.170 |
Why?
|
| Sirtuin 1 | 1 | 2020 | 47 | 0.170 |
Why?
|
| Oxygen Consumption | 3 | 2018 | 303 | 0.170 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 666 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2010 | 657 | 0.170 |
Why?
|
| Thromboxane B2 | 7 | 1989 | 20 | 0.170 |
Why?
|
| DNA, Complementary | 3 | 2006 | 463 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 996 | 0.170 |
Why?
|
| In Situ Hybridization | 4 | 2006 | 473 | 0.170 |
Why?
|
| Global Health | 3 | 2009 | 557 | 0.160 |
Why?
|
| WT1 Proteins | 3 | 2005 | 27 | 0.160 |
Why?
|
| Ureteral Obstruction | 3 | 1990 | 105 | 0.160 |
Why?
|
| Proteins | 2 | 2003 | 1038 | 0.160 |
Why?
|
| Female | 38 | 2015 | 65309 | 0.160 |
Why?
|
| Thymosin | 2 | 2010 | 24 | 0.160 |
Why?
|
| NF-kappa B | 1 | 2001 | 459 | 0.160 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 571 | 0.160 |
Why?
|
| Nephrectomy | 3 | 1989 | 172 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2018 | 151 | 0.150 |
Why?
|
| Thromboxane A2 | 4 | 1993 | 19 | 0.150 |
Why?
|
| Mitochondria, Heart | 1 | 2018 | 60 | 0.150 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1996 | 74 | 0.150 |
Why?
|
| Immunohistochemistry | 7 | 2008 | 1684 | 0.150 |
Why?
|
| DNA | 5 | 1996 | 1592 | 0.150 |
Why?
|
| Protein Precursors | 2 | 2010 | 149 | 0.150 |
Why?
|
| Chromosome Mapping | 4 | 2008 | 1083 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2020 | 209 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 549 | 0.150 |
Why?
|
| Oligonucleotides | 1 | 1998 | 88 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 281 | 0.150 |
Why?
|
| Apolipoprotein L1 | 3 | 2012 | 11 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 554 | 0.140 |
Why?
|
| Renin-Angiotensin System | 1 | 1998 | 95 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 3 | 2008 | 1335 | 0.140 |
Why?
|
| Mice, Knockout | 6 | 2018 | 3710 | 0.140 |
Why?
|
| Imidazoles | 5 | 1992 | 199 | 0.140 |
Why?
|
| Arachidonic Acids | 2 | 1988 | 20 | 0.140 |
Why?
|
| Phenotype | 6 | 2006 | 4221 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 8 | 2018 | 4342 | 0.140 |
Why?
|
| T-Lymphocytes | 4 | 2006 | 1677 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2008 | 1684 | 0.130 |
Why?
|
| Human Immunodeficiency Virus Proteins | 2 | 2022 | 3 | 0.130 |
Why?
|
| Cell Communication | 2 | 2011 | 165 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 1996 | 123 | 0.130 |
Why?
|
| Protein Binding | 4 | 2010 | 1741 | 0.130 |
Why?
|
| HIV-2 | 1 | 1995 | 8 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2013 | 515 | 0.130 |
Why?
|
| HIV Core Protein p24 | 1 | 1995 | 12 | 0.130 |
Why?
|
| DNA Primers | 4 | 2007 | 661 | 0.130 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 1267 | 0.130 |
Why?
|
| Extracellular Matrix | 3 | 1994 | 231 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2013 | 1102 | 0.130 |
Why?
|
| New York | 3 | 2007 | 68 | 0.130 |
Why?
|
| Skin Diseases | 2 | 1995 | 122 | 0.120 |
Why?
|
| Fusion Proteins, gag-pol | 3 | 2013 | 4 | 0.120 |
Why?
|
| Benzoates | 2 | 2012 | 20 | 0.120 |
Why?
|
| Tetrahydronaphthalenes | 2 | 2012 | 29 | 0.120 |
Why?
|
| Retinoic Acid Receptor alpha | 3 | 2012 | 18 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1994 | 54 | 0.120 |
Why?
|
| Ureter | 3 | 2004 | 96 | 0.120 |
Why?
|
| Blood Pressure | 10 | 2012 | 1314 | 0.120 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1994 | 60 | 0.120 |
Why?
|
| RNA | 3 | 2004 | 577 | 0.120 |
Why?
|
| Arterioles | 1 | 1994 | 27 | 0.120 |
Why?
|
| Gentamicins | 2 | 1985 | 95 | 0.120 |
Why?
|
| Hepatitis C | 2 | 2008 | 365 | 0.110 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1993 | 5 | 0.110 |
Why?
|
| Hemodynamics | 7 | 1998 | 850 | 0.110 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 77 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 666 | 0.110 |
Why?
|
| Transcription, Genetic | 4 | 2008 | 1695 | 0.110 |
Why?
|
| Mortality | 1 | 2015 | 228 | 0.110 |
Why?
|
| Iohexol | 1 | 2013 | 20 | 0.110 |
Why?
|
| GTPase-Activating Proteins | 1 | 2014 | 85 | 0.110 |
Why?
|
| Biphenyl Compounds | 3 | 1991 | 56 | 0.110 |
Why?
|
| Biomarkers | 5 | 2013 | 2940 | 0.110 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 1993 | 62 | 0.110 |
Why?
|
| Heptanoic Acids | 3 | 1991 | 77 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 617 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2018 | 766 | 0.110 |
Why?
|
| Radioisotope Renography | 2 | 1996 | 3 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2015 | 264 | 0.110 |
Why?
|
| Ki-67 Antigen | 2 | 2005 | 113 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2012 | 160 | 0.110 |
Why?
|
| Hypertrophy | 3 | 2002 | 100 | 0.110 |
Why?
|
| Heparitin Sulfate | 2 | 2008 | 20 | 0.110 |
Why?
|
| Lymphocytes | 2 | 1999 | 403 | 0.110 |
Why?
|
| Prostaglandins | 3 | 1989 | 48 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 207 | 0.110 |
Why?
|
| Proviruses | 3 | 2006 | 17 | 0.110 |
Why?
|
| Prednisone | 2 | 2004 | 273 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2014 | 270 | 0.100 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 74 | 0.100 |
Why?
|
| Atrial Natriuretic Factor | 2 | 1990 | 52 | 0.100 |
Why?
|
| Basement Membrane | 3 | 2003 | 46 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 66 | 0.100 |
Why?
|
| Sarcoma, Experimental | 1 | 1992 | 16 | 0.100 |
Why?
|
| Gene Expression Profiling | 5 | 2013 | 1684 | 0.100 |
Why?
|
| Methacrylates | 3 | 1989 | 16 | 0.100 |
Why?
|
| Femoral Artery | 1 | 2013 | 190 | 0.100 |
Why?
|
| Nephritis | 1 | 2012 | 20 | 0.100 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 893 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 195 | 0.100 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2012 | 6 | 0.100 |
Why?
|
| Response Elements | 1 | 2012 | 97 | 0.100 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1991 | 6 | 0.100 |
Why?
|
| Viral Load | 3 | 2002 | 382 | 0.100 |
Why?
|
| Dehydration | 1 | 1991 | 37 | 0.100 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2011 | 16 | 0.100 |
Why?
|
| Angiography | 2 | 1989 | 215 | 0.100 |
Why?
|
| Potassium Chloride | 2 | 1992 | 54 | 0.100 |
Why?
|
| Epithelium | 3 | 2000 | 366 | 0.100 |
Why?
|
| Aminopyridines | 1 | 2012 | 53 | 0.100 |
Why?
|
| Physician's Role | 2 | 2011 | 164 | 0.100 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 1991 | 39 | 0.100 |
Why?
|
| Creatinine | 5 | 2013 | 379 | 0.100 |
Why?
|
| Benzamides | 1 | 2012 | 107 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 110 | 0.090 |
Why?
|
| Cell Nucleus | 2 | 2008 | 674 | 0.090 |
Why?
|
| Aged | 12 | 2013 | 19035 | 0.090 |
Why?
|
| Renal Veins | 3 | 2002 | 35 | 0.090 |
Why?
|
| Cyclopropanes | 2 | 2012 | 67 | 0.090 |
Why?
|
| Cell Transformation, Viral | 1 | 1991 | 106 | 0.090 |
Why?
|
| Prognosis | 5 | 2015 | 4490 | 0.090 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1991 | 30 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2013 | 202 | 0.090 |
Why?
|
| Monocytes | 1 | 1993 | 347 | 0.090 |
Why?
|
| Electrophysiology | 2 | 2005 | 268 | 0.090 |
Why?
|
| Aprotinin | 2 | 1987 | 11 | 0.090 |
Why?
|
| Heart Auscultation | 1 | 1990 | 7 | 0.090 |
Why?
|
| Heart Murmurs | 1 | 1990 | 15 | 0.090 |
Why?
|
| Guanylate Kinases | 1 | 2010 | 17 | 0.090 |
Why?
|
| Gene Products, tat | 3 | 1995 | 28 | 0.090 |
Why?
|
| Inulin | 5 | 1989 | 18 | 0.090 |
Why?
|
| Cell Polarity | 2 | 2002 | 125 | 0.090 |
Why?
|
| Veterans | 1 | 2022 | 1725 | 0.090 |
Why?
|
| Epidermal Growth Factor | 1 | 1991 | 122 | 0.090 |
Why?
|
| Career Choice | 1 | 2011 | 143 | 0.090 |
Why?
|
| International Cooperation | 1 | 2011 | 160 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 1013 | 0.090 |
Why?
|
| Research Personnel | 1 | 2011 | 118 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2010 | 80 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1995 | 443 | 0.090 |
Why?
|
| Malpractice | 1 | 2010 | 55 | 0.090 |
Why?
|
| Aorta | 1 | 2013 | 540 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 198 | 0.090 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2010 | 28 | 0.090 |
Why?
|
| Rats, Inbred SHR | 1 | 1989 | 64 | 0.080 |
Why?
|
| Mentors | 1 | 2011 | 145 | 0.080 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2009 | 13 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2010 | 107 | 0.080 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 2009 | 4 | 0.080 |
Why?
|
| History, 21st Century | 2 | 2009 | 272 | 0.080 |
Why?
|
| Lipocalins | 1 | 2009 | 25 | 0.080 |
Why?
|
| Adipokines | 1 | 2010 | 58 | 0.080 |
Why?
|
| DNA Replication | 1 | 1991 | 343 | 0.080 |
Why?
|
| Acute-Phase Proteins | 1 | 2009 | 46 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 143 | 0.080 |
Why?
|
| Nobel Prize | 1 | 2009 | 8 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2009 | 414 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2010 | 2837 | 0.080 |
Why?
|
| Data Collection | 1 | 2011 | 386 | 0.080 |
Why?
|
| LLC-PK1 Cells | 1 | 2008 | 1 | 0.080 |
Why?
|
| Acrylates | 1 | 1989 | 12 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2009 | 384 | 0.080 |
Why?
|
| Malates | 1 | 2008 | 7 | 0.080 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2008 | 25 | 0.080 |
Why?
|
| Receptors, Fibronectin | 3 | 1993 | 8 | 0.080 |
Why?
|
| Genetic Markers | 3 | 2005 | 607 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2012 | 2577 | 0.080 |
Why?
|
| Survival Analysis | 4 | 2011 | 1470 | 0.080 |
Why?
|
| Genetic Variation | 2 | 2012 | 1479 | 0.080 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2008 | 1 | 0.080 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2009 | 92 | 0.080 |
Why?
|
| Upstream Stimulatory Factors | 1 | 2008 | 8 | 0.080 |
Why?
|
| Home Care Services | 1 | 2009 | 67 | 0.080 |
Why?
|
| Single-Payer System | 1 | 2008 | 1 | 0.080 |
Why?
|
| Capitalism | 1 | 2008 | 1 | 0.080 |
Why?
|
| Giant Cells | 1 | 2008 | 34 | 0.080 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2006 | 23 | 0.080 |
Why?
|
| National Health Insurance, United States | 1 | 2008 | 3 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 396 | 0.080 |
Why?
|
| Faculty, Medical | 1 | 2011 | 263 | 0.080 |
Why?
|
| Unemployment | 1 | 2008 | 20 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2008 | 8 | 0.080 |
Why?
|
| Aging | 4 | 2005 | 1173 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 110 | 0.070 |
Why?
|
| Binding Sites | 3 | 2005 | 1292 | 0.070 |
Why?
|
| Nifedipine | 1 | 1987 | 21 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 1989 | 242 | 0.070 |
Why?
|
| Dependovirus | 2 | 1999 | 119 | 0.070 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2008 | 44 | 0.070 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2008 | 31 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 282 | 0.070 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2008 | 63 | 0.070 |
Why?
|
| Age Factors | 2 | 2007 | 2801 | 0.070 |
Why?
|
| Medically Uninsured | 1 | 2008 | 73 | 0.070 |
Why?
|
| Fish Oils | 1 | 1988 | 82 | 0.070 |
Why?
|
| Alkynes | 1 | 2007 | 26 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 391 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 348 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2008 | 100 | 0.070 |
Why?
|
| Muscles | 1 | 2008 | 288 | 0.070 |
Why?
|
| Tenofovir | 1 | 2007 | 16 | 0.070 |
Why?
|
| Paraffin Embedding | 1 | 2007 | 30 | 0.070 |
Why?
|
| Staining and Labeling | 2 | 2001 | 183 | 0.070 |
Why?
|
| Animals, Newborn | 4 | 1995 | 988 | 0.070 |
Why?
|
| Plasmids | 2 | 2007 | 511 | 0.070 |
Why?
|
| Sensitivity and Specificity | 6 | 2006 | 2021 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2013 | 793 | 0.070 |
Why?
|
| Hepacivirus | 1 | 2008 | 241 | 0.070 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 3 | 1995 | 31 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 465 | 0.070 |
Why?
|
| Autoradiography | 3 | 1995 | 71 | 0.070 |
Why?
|
| p-Aminohippuric Acid | 4 | 1988 | 5 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2008 | 619 | 0.070 |
Why?
|
| Ethiopia | 1 | 2006 | 21 | 0.070 |
Why?
|
| Genes, gag | 1 | 2006 | 7 | 0.070 |
Why?
|
| Genes, pol | 1 | 2006 | 10 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2002 | 1870 | 0.070 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2006 | 10 | 0.070 |
Why?
|
| Israel | 1 | 2006 | 44 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2009 | 225 | 0.070 |
Why?
|
| DNA Damage | 1 | 2009 | 506 | 0.070 |
Why?
|
| Tropism | 1 | 2006 | 9 | 0.070 |
Why?
|
| Reassortant Viruses | 1 | 2006 | 34 | 0.070 |
Why?
|
| Dietary Fats | 1 | 1988 | 296 | 0.070 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2006 | 16 | 0.070 |
Why?
|
| Kidney Cortex | 1 | 1985 | 20 | 0.060 |
Why?
|
| Hydronephrosis | 1 | 1986 | 35 | 0.060 |
Why?
|
| Primates | 1 | 2006 | 81 | 0.060 |
Why?
|
| Proteoglycans | 2 | 1998 | 93 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 3 | 1999 | 262 | 0.060 |
Why?
|
| Bradykinin | 1 | 1985 | 57 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2005 | 317 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2007 | 1088 | 0.060 |
Why?
|
| Myocardial Contraction | 2 | 2018 | 261 | 0.060 |
Why?
|
| Least-Squares Analysis | 1 | 2005 | 30 | 0.060 |
Why?
|
| Phylogeny | 2 | 2009 | 684 | 0.060 |
Why?
|
| Swine | 1 | 2008 | 1155 | 0.060 |
Why?
|
| Biological Transport, Active | 1 | 2005 | 87 | 0.060 |
Why?
|
| Allosteric Regulation | 1 | 2005 | 48 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2004 | 284 | 0.060 |
Why?
|
| Regional Blood Flow | 4 | 1994 | 210 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 86 | 0.060 |
Why?
|
| Dimerization | 1 | 2005 | 144 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2007 | 383 | 0.060 |
Why?
|
| Cyclin E | 1 | 2004 | 29 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 239 | 0.060 |
Why?
|
| Nephrosclerosis | 2 | 2008 | 7 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2000 | 98 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2005 | 168 | 0.060 |
Why?
|
| Nepovirus | 1 | 2004 | 1 | 0.060 |
Why?
|
| Chromatography, Affinity | 2 | 2002 | 70 | 0.060 |
Why?
|
| Antihypertensive Agents | 3 | 2012 | 392 | 0.060 |
Why?
|
| Neprilysin | 1 | 2003 | 19 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 3283 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2003 | 48 | 0.060 |
Why?
|
| Mice, Inbred Strains | 3 | 2013 | 310 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2006 | 771 | 0.060 |
Why?
|
| Forecasting | 1 | 2005 | 355 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2005 | 399 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 445 | 0.060 |
Why?
|
| Bicarbonates | 1 | 1983 | 98 | 0.060 |
Why?
|
| Growth Disorders | 2 | 1996 | 207 | 0.050 |
Why?
|
| Age Distribution | 2 | 2001 | 410 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2013 | 1148 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2005 | 357 | 0.050 |
Why?
|
| Vasoconstriction | 2 | 1996 | 104 | 0.050 |
Why?
|
| Rats, Inbred ACI | 5 | 1990 | 5 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 1993 | 137 | 0.050 |
Why?
|
| Hippocratic Oath | 1 | 2002 | 5 | 0.050 |
Why?
|
| Homozygote | 2 | 1995 | 533 | 0.050 |
Why?
|
| Acute Kidney Injury | 2 | 2008 | 607 | 0.050 |
Why?
|
| Gene Products, env | 1 | 2002 | 15 | 0.050 |
Why?
|
| Hyperinsulinism | 1 | 2002 | 68 | 0.050 |
Why?
|
| Injections, Intra-Arterial | 1 | 2002 | 16 | 0.050 |
Why?
|
| alpha-Galactosidase | 1 | 2002 | 20 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 1067 | 0.050 |
Why?
|
| Eicosanoids | 3 | 1990 | 13 | 0.050 |
Why?
|
| Clone Cells | 1 | 2002 | 163 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2004 | 184 | 0.050 |
Why?
|
| Leucine | 1 | 2003 | 309 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 769 | 0.050 |
Why?
|
| Survival Rate | 2 | 2015 | 1993 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 279 | 0.050 |
Why?
|
| Genetic Engineering | 2 | 2004 | 161 | 0.050 |
Why?
|
| Kidney Function Tests | 4 | 1996 | 126 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 939 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 41 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 164 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 752 | 0.050 |
Why?
|
| Axons | 1 | 2004 | 381 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 424 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 298 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2022 | 1002 | 0.050 |
Why?
|
| Minoxidil | 2 | 1979 | 5 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2002 | 1002 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2001 | 35 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2001 | 294 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2002 | 623 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 53 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 123 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2001 | 288 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 515 | 0.040 |
Why?
|
| Ligands | 2 | 2013 | 533 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 355 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2002 | 379 | 0.040 |
Why?
|
| Macrophages | 3 | 2010 | 607 | 0.040 |
Why?
|
| Receptors, Prostaglandin | 2 | 1990 | 22 | 0.040 |
Why?
|
| Subtraction Technique | 2 | 1989 | 36 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2008 | 6023 | 0.040 |
Why?
|
| Genotype | 2 | 2004 | 2546 | 0.040 |
Why?
|
| Heterozygote | 2 | 2008 | 671 | 0.040 |
Why?
|
| Transplantation Immunology | 1 | 1999 | 53 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 481 | 0.040 |
Why?
|
| Mitogens | 1 | 1999 | 30 | 0.040 |
Why?
|
| False Positive Reactions | 2 | 2006 | 145 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2020 | 116 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 3359 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2009 | 66 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2018 | 51 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2018 | 42 | 0.040 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 43 | 0.040 |
Why?
|
| Radioimmunoassay | 2 | 1991 | 109 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 95 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 101 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2018 | 85 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 126 | 0.040 |
Why?
|
| Chromosomes | 2 | 2009 | 198 | 0.040 |
Why?
|
| Cats | 1 | 1998 | 117 | 0.040 |
Why?
|
| Education, Medical | 1 | 2002 | 285 | 0.040 |
Why?
|
| Drug Evaluation | 1 | 1998 | 111 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1999 | 150 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 1998 | 39 | 0.040 |
Why?
|
| Spleen | 3 | 1994 | 272 | 0.040 |
Why?
|
| Hospitalization | 2 | 2022 | 1732 | 0.040 |
Why?
|
| Enalapril | 2 | 1996 | 18 | 0.040 |
Why?
|
| Pyrimidines | 2 | 1979 | 374 | 0.040 |
Why?
|
| Thymidine | 2 | 2001 | 53 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 1996 | 22 | 0.040 |
Why?
|
| Biological Transport | 1 | 1998 | 347 | 0.040 |
Why?
|
| Kinetics | 2 | 1991 | 1313 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 376 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 327 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 2 | 1988 | 141 | 0.040 |
Why?
|
| Logistic Models | 1 | 2022 | 1796 | 0.040 |
Why?
|
| Crosses, Genetic | 2 | 2009 | 161 | 0.030 |
Why?
|
| Research Design | 2 | 2011 | 688 | 0.030 |
Why?
|
| Arachidonic Acid | 2 | 1988 | 70 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 1997 | 204 | 0.030 |
Why?
|
| Random Allocation | 2 | 1987 | 423 | 0.030 |
Why?
|
| Vascular Resistance | 3 | 1990 | 188 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2011 | 2105 | 0.030 |
Why?
|
| Smoking | 1 | 2022 | 1032 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 1977 | 121 | 0.030 |
Why?
|
| Genes, tat | 1 | 1996 | 10 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 1996 | 95 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2012 | 12087 | 0.030 |
Why?
|
| Deoxyribonuclease I | 2 | 1992 | 49 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 1992 | 1585 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1996 | 304 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 1995 | 70 | 0.030 |
Why?
|
| Renal Replacement Therapy | 2 | 2009 | 141 | 0.030 |
Why?
|
| Heart Rate | 5 | 1988 | 585 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1995 | 47 | 0.030 |
Why?
|
| AIDS Dementia Complex | 1 | 1995 | 12 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 481 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1995 | 73 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 500 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 1390 | 0.030 |
Why?
|
| Oncogenes | 1 | 1995 | 169 | 0.030 |
Why?
|
| United Kingdom | 1 | 2015 | 195 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2000 | 945 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1995 | 132 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 1993 | 1063 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 647 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1995 | 80 | 0.030 |
Why?
|
| Rats, Inbred WKY | 2 | 1996 | 54 | 0.030 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1994 | 38 | 0.030 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2014 | 2 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1994 | 7 | 0.030 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2014 | 12 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 1994 | 7 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 1926 | 0.030 |
Why?
|
| Paraparesis, Tropical Spastic | 1 | 1993 | 2 | 0.030 |
Why?
|
| Integrin beta1 | 1 | 2014 | 54 | 0.030 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1993 | 11 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 69 | 0.030 |
Why?
|
| Leukotriene Antagonists | 1 | 1994 | 17 | 0.030 |
Why?
|
| Integrin alpha4beta1 | 1 | 1993 | 17 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1995 | 441 | 0.030 |
Why?
|
| Glucose | 1 | 2018 | 869 | 0.030 |
Why?
|
| Isomerism | 1 | 1993 | 31 | 0.030 |
Why?
|
| Chromatin | 1 | 1997 | 552 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1760 | 0.030 |
Why?
|
| Sarcoma, Kaposi | 1 | 1995 | 120 | 0.030 |
Why?
|
| Kenya | 1 | 2013 | 51 | 0.030 |
Why?
|
| Teratoma | 2 | 1991 | 123 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2022 | 15930 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2008 | 381 | 0.030 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1993 | 17 | 0.030 |
Why?
|
| Receptors, HIV | 1 | 1993 | 3 | 0.030 |
Why?
|
| Sclerosis | 1 | 2013 | 32 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2009 | 611 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 1994 | 330 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1993 | 104 | 0.030 |
Why?
|
| Dibenzazepines | 1 | 2013 | 2 | 0.030 |
Why?
|
| Receptor, Notch4 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 56 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2013 | 20 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 796 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 21 | 0.030 |
Why?
|
| Receptors, Thromboxane | 2 | 1990 | 5 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2008 | 4705 | 0.030 |
Why?
|
| Benzazepines | 1 | 2013 | 64 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 469 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2013 | 62 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2013 | 54 | 0.030 |
Why?
|
| Dipeptides | 1 | 2013 | 56 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2013 | 240 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 247 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1995 | 237 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2002 | 1224 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1992 | 30 | 0.030 |
Why?
|
| Cataract | 1 | 1995 | 218 | 0.030 |
Why?
|
| Pregnancy | 2 | 1996 | 7115 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 1994 | 374 | 0.030 |
Why?
|
| Iodohippuric Acid | 1 | 1991 | 2 | 0.020 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1991 | 9 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2012 | 39 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2018 | 991 | 0.020 |
Why?
|
| Natriuresis | 1 | 1992 | 37 | 0.020 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 1991 | 3 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2011 | 1166 | 0.020 |
Why?
|
| CREB-Binding Protein | 1 | 2012 | 63 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 1991 | 804 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1991 | 75 | 0.020 |
Why?
|
| Genome, Human | 1 | 2018 | 1266 | 0.020 |
Why?
|
| Peptides | 2 | 1994 | 798 | 0.020 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1991 | 39 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 1994 | 527 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 2595 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 233 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1991 | 65 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1991 | 185 | 0.020 |
Why?
|
| Clinical Enzyme Tests | 1 | 1991 | 14 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1991 | 210 | 0.020 |
Why?
|
| Cyclosporine | 1 | 1992 | 146 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1991 | 96 | 0.020 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2010 | 17 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2010 | 20 | 0.020 |
Why?
|
| Retinoids | 1 | 2010 | 33 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1991 | 110 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 429 | 0.020 |
Why?
|
| Amino Acid Isomerases | 1 | 1990 | 6 | 0.020 |
Why?
|
| Cost Control | 1 | 2010 | 24 | 0.020 |
Why?
|
| Placenta | 1 | 1995 | 493 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 714 | 0.020 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1990 | 37 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 234 | 0.020 |
Why?
|
| Infant | 3 | 1994 | 12286 | 0.020 |
Why?
|
| Pyridines | 1 | 1992 | 222 | 0.020 |
Why?
|
| Policy Making | 1 | 2010 | 59 | 0.020 |
Why?
|
| Public Policy | 1 | 2010 | 51 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 258 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2010 | 45 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1991 | 293 | 0.020 |
Why?
|
| Subcutaneous Tissue | 1 | 2010 | 15 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2011 | 143 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2006 | 327 | 0.020 |
Why?
|
| Body Weight | 1 | 1994 | 999 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 519 | 0.020 |
Why?
|
| Ligation | 1 | 1990 | 132 | 0.020 |
Why?
|
| Politics | 1 | 2010 | 58 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 28 | 0.020 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1989 | 10 | 0.020 |
Why?
|
| Aminohippuric Acids | 1 | 1989 | 2 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 298 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 82 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 1989 | 3 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 114 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 55 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1989 | 501 | 0.020 |
Why?
|
| Lipocalin-2 | 1 | 2009 | 28 | 0.020 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2009 | 5 | 0.020 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 2 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 1989 | 20 | 0.020 |
Why?
|
| Adiponectin | 1 | 2010 | 109 | 0.020 |
Why?
|
| Antigens, CD | 1 | 1991 | 420 | 0.020 |
Why?
|
| Renal Artery | 1 | 1989 | 73 | 0.020 |
Why?
|
| Weight Loss | 1 | 2013 | 478 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1991 | 678 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2008 | 16 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 1989 | 41 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2010 | 76 | 0.020 |
Why?
|
| Physicians, Family | 1 | 2009 | 38 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1989 | 27 | 0.020 |
Why?
|
| Indinavir | 1 | 2008 | 6 | 0.020 |
Why?
|
| Thrombosis | 1 | 1994 | 517 | 0.020 |
Why?
|
| Diuretics | 2 | 1987 | 158 | 0.020 |
Why?
|
| Public Health | 1 | 2011 | 261 | 0.020 |
Why?
|
| HIV Protease Inhibitors | 1 | 2008 | 53 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 1990 | 268 | 0.020 |
Why?
|
| Leptin | 1 | 2010 | 211 | 0.020 |
Why?
|
| Prazosin | 1 | 1988 | 14 | 0.020 |
Why?
|
| Prostaglandins F | 1 | 1988 | 9 | 0.020 |
Why?
|
| Fats | 1 | 1988 | 13 | 0.020 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 1988 | 6 | 0.020 |
Why?
|
| Benzothiadiazines | 1 | 1987 | 6 | 0.020 |
Why?
|
| Reference Values | 1 | 1989 | 696 | 0.020 |
Why?
|
| Radiography | 1 | 1990 | 818 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 393 | 0.020 |
Why?
|
| Morbidity | 1 | 2008 | 240 | 0.020 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 1987 | 34 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1990 | 217 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2009 | 454 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1987 | 110 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2007 | 51 | 0.020 |
Why?
|
| Food, Fortified | 1 | 1988 | 96 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2010 | 374 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 670 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 1303 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2011 | 678 | 0.020 |
Why?
|
| Transplantation, Isogeneic | 1 | 1986 | 14 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1999 | 79 | 0.020 |
Why?
|
| Placebos | 1 | 1987 | 238 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 426 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1987 | 209 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 1986 | 68 | 0.020 |
Why?
|
| Medicaid | 1 | 2009 | 242 | 0.020 |
Why?
|
| Transplantation, Homologous | 3 | 1999 | 657 | 0.020 |
Why?
|
| Receptors, CCR3 | 1 | 2006 | 5 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 750 | 0.020 |
Why?
|
| Receptors, CXCR6 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1986 | 8 | 0.020 |
Why?
|
| Inflammation | 3 | 2008 | 1400 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2013 | 831 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 663 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2011 | 483 | 0.020 |
Why?
|
| Chimerism | 1 | 2006 | 28 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2006 | 44 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 57 | 0.020 |
Why?
|
| Quinacrine | 1 | 1985 | 3 | 0.020 |
Why?
|
| Oligomycins | 1 | 1985 | 4 | 0.020 |
Why?
|
| Antimycin A | 1 | 1985 | 6 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1987 | 730 | 0.020 |
Why?
|
| Rotenone | 1 | 1985 | 16 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2848 | 0.020 |
Why?
|
| Adenine Nucleotides | 1 | 1985 | 41 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2002 | 1313 | 0.020 |
Why?
|
| Family | 1 | 2009 | 576 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1988 | 302 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 377 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2006 | 104 | 0.020 |
Why?
|
| Dinoprostone | 1 | 1986 | 76 | 0.020 |
Why?
|
| Medicare | 1 | 2009 | 423 | 0.020 |
Why?
|
| Aminoglycosides | 1 | 1985 | 45 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2008 | 496 | 0.020 |
Why?
|
| Indomethacin | 1 | 1985 | 84 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 3259 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1990 | 1021 | 0.020 |
Why?
|
| Lipids | 1 | 1988 | 513 | 0.010 |
Why?
|
| Rabbits | 1 | 1985 | 696 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1999 | 462 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 19029 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 2004 | 95 | 0.010 |
Why?
|
| Absorption | 1 | 1983 | 52 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 590 | 0.010 |
Why?
|
| Catalysis | 1 | 2004 | 125 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 281 | 0.010 |
Why?
|
| Animals, Outbred Strains | 1 | 2002 | 13 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 317 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1985 | 420 | 0.010 |
Why?
|
| Humanism | 1 | 2002 | 5 | 0.010 |
Why?
|
| Ethics, Professional | 1 | 2002 | 18 | 0.010 |
Why?
|
| Cardiac Output | 2 | 1987 | 168 | 0.010 |
Why?
|
| Altruism | 1 | 2002 | 26 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 391 | 0.010 |
Why?
|
| House Calls | 1 | 2002 | 37 | 0.010 |
Why?
|
| Social Responsibility | 1 | 2002 | 79 | 0.010 |
Why?
|
| Agar | 1 | 2001 | 16 | 0.010 |
Why?
|
| DNA, Circular | 1 | 2001 | 18 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 80 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 3657 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2002 | 494 | 0.010 |
Why?
|
| Culture Media | 1 | 2001 | 182 | 0.010 |
Why?
|
| Gene Products, pol | 1 | 2000 | 5 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 2000 | 19 | 0.010 |
Why?
|
| Teaching | 1 | 2002 | 182 | 0.010 |
Why?
|
| Mitochondria | 1 | 1985 | 682 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 810 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2002 | 229 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 359 | 0.010 |
Why?
|
| Isoantigens | 1 | 1999 | 18 | 0.010 |
Why?
|
| Lac Operon | 1 | 1999 | 94 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 8840 | 0.010 |
Why?
|
| Aldosterone | 1 | 1979 | 59 | 0.010 |
Why?
|
| Informed Consent | 1 | 2002 | 342 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 1999 | 23 | 0.010 |
Why?
|
| A Kinase Anchor Proteins | 1 | 1999 | 18 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1999 | 96 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1987 | 5031 | 0.010 |
Why?
|
| Sodium | 1 | 1979 | 290 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 1294 | 0.010 |
Why?
|
| Liposomes | 1 | 1998 | 168 | 0.010 |
Why?
|
| Leukocyte Common Antigens | 1 | 1997 | 90 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1996 | 20 | 0.010 |
Why?
|
| Curriculum | 1 | 2002 | 718 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1977 | 76 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1996 | 287 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1994 | 46 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1994 | 44 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1994 | 99 | 0.010 |
Why?
|
| Viremia | 1 | 1994 | 126 | 0.010 |
Why?
|
| Dicarboxylic Acids | 1 | 1994 | 34 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1994 | 118 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1993 | 28 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1994 | 253 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 313 | 0.010 |
Why?
|
| Indoles | 1 | 1994 | 181 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1994 | 346 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2002 | 1158 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 187 | 0.010 |
Why?
|
| Colon | 1 | 1994 | 353 | 0.010 |
Why?
|
| Graft Survival | 1 | 1994 | 524 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1991 | 312 | 0.010 |
Why?
|
| Introns | 1 | 1991 | 302 | 0.010 |
Why?
|
| Child | 2 | 2005 | 24144 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1990 | 44 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 85 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1990 | 32 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 396 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1990 | 228 | 0.010 |
Why?
|
| Calcitriol | 1 | 1989 | 80 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1989 | 263 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1991 | 638 | 0.000 |
Why?
|
| Blood Flow Velocity | 1 | 1990 | 447 | 0.000 |
Why?
|
| Doxazosin | 1 | 1988 | 27 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1988 | 175 | 0.000 |
Why?
|
| Microspheres | 1 | 1987 | 70 | 0.000 |
Why?
|
| Vitamin D | 1 | 1989 | 159 | 0.000 |
Why?
|
| Lung | 1 | 1994 | 1468 | 0.000 |
Why?
|
| Dogs | 1 | 1987 | 763 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1987 | 203 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1988 | 350 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1987 | 525 | 0.000 |
Why?
|
| Blood Volume | 1 | 1979 | 80 | 0.000 |
Why?
|
| Propranolol | 1 | 1979 | 128 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1994 | 13819 | 0.000 |
Why?
|
| Potassium | 1 | 1979 | 278 | 0.000 |
Why?
|